Header cover image

Chinese (SSE) Pharma Industry Analysis

UpdatedDec 10, 2023
DataAggregated Company Financials
Companies221
  • 7D-2.5%
  • 3M9.5%
  • 1Y-4.7%
  • YTD0.3%

In the last week, the Pharma industry is down 2.8% with Asymchem Laboratories (Tianjin) down the most at 14%. In contrast, Tonghua Golden-Horse Pharmaceutical Industry CoLtd has gained 36%. However, the industry is down 4.9% over the past year. Looking forward, earnings are forecast to grow by 21% annually.

Industry Valuation and Performance

Has the Chinese Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 10 Dec 2023CN„2.8tCN„827.9bCN„79.7b30.8x35.6x3.4x
Tue, 07 Nov 2023CN„2.8tCN„820.6bCN„78.7b31.6x36.1x3.5x
Thu, 05 Oct 2023CN„2.8tCN„824.9bCN„78.6b32.3x35.8x3.4x
Sat, 02 Sep 2023CN„2.6tCN„824.5bCN„78.5b30x33.7x3.2x
Mon, 31 Jul 2023CN„2.8tCN„811.0bCN„76.9b32.5x36.8x3.5x
Wed, 28 Jun 2023CN„2.8tCN„809.7bCN„76.5b31.6x36.5x3.4x
Fri, 26 May 2023CN„3.0tCN„809.1bCN„76.5b34.3x39.1x3.7x
Sun, 23 Apr 2023CN„3.0tCN„802.5bCN„90.5b33x32.6x3.7x
Tue, 21 Mar 2023CN„2.8tCN„791.7bCN„87.2b35.4x32.4x3.6x
Thu, 16 Feb 2023CN„3.0tCN„774.5bCN„83.0b36.9x35.6x3.8x
Sat, 14 Jan 2023CN„2.8tCN„772.3bCN„82.1b35.2x34.7x3.7x
Mon, 12 Dec 2022CN„2.9tCN„767.8bCN„81.9b37.9x34.9x3.7x
Wed, 09 Nov 2022CN„2.7tCN„767.3bCN„81.7b34.9x33.4x3.6x
Fri, 07 Oct 2022CN„2.4tCN„760.3bCN„79.5b30.4x30.3x3.2x
Sun, 04 Sep 2022CN„2.6tCN„752.8bCN„78.8b31.9x32.4x3.4x
Tue, 02 Aug 2022CN„2.6tCN„745.3bCN„80.2b31.6x32.5x3.5x
Thu, 30 Jun 2022CN„2.7tCN„739.5bCN„81.9b32.2x33.6x3.7x
Sat, 28 May 2022CN„2.5tCN„740.4bCN„81.6b32x31.1x3.4x
Mon, 25 Apr 2022CN„2.5tCN„727.5bCN„76.5b31.1x32.3x3.4x
Wed, 23 Mar 2022CN„2.9tCN„724.7bCN„76.7b35.2x37.2x3.9x
Fri, 18 Feb 2022CN„2.8tCN„721.5bCN„73.6b32.3x37.4x3.8x
Sun, 16 Jan 2022CN„3.2tCN„720.2bCN„73.5b40x43.1x4.4x
Tue, 14 Dec 2021CN„3.0tCN„718.2bCN„73.2b32.4x41.2x4.2x
Thu, 11 Nov 2021CN„2.9tCN„716.7bCN„73.0b30.4x39.8x4x
Sat, 09 Oct 2021CN„2.9tCN„704.7bCN„73.1b31.9x39.8x4.1x
Mon, 06 Sep 2021CN„2.8tCN„702.7bCN„71.2b31x39.8x4x
Wed, 04 Aug 2021CN„3.0tCN„702.6bCN„71.1b30.4x42.6x4.3x
Sat, 08 May 2021CN„3.1tCN„680.1bCN„69.6b32.6x44.7x4.6x
Tue, 09 Feb 2021CN„3.0tCN„646.4bCN„64.7b32x45.8x4.6x
Price to Earnings Ratio

47.4x


Total Market Cap: CN„3.1tTotal Earnings: CN„64.7bTotal Revenue: CN„646.4bTotal Market Cap vs Earnings and Revenue0%0%0%
Chinese Pharma Industry Price to Earnings3Y Average 37.8x20222023
Current Industry PE
  • Investors are relatively neutral on the Chinese Pharmaceuticals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PE ratio of 37.8x.
  • The 3-year average PS ratio of 3.9x is higher than the industry's current PS ratio of 3.4x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 7.2% per year over the last three years.
  • Revenues for these companies have grown 8.6% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Comparison

How does Chinese Pharma compare with similar industries?

CN Market-2.03%
Healthcare-2.49%
Pharma-2.48%
Pharma-2.48%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
766 Tonghua Golden-Horse Pharmaceutical Industry CoLtdCN„23.6635.6%
+CN„6.0b
293.7%PE688x
688578 Shanghai Allist PharmaceuticalsCN„46.6921.3%
+CN„3.7b
129.8%PE43.1x
300255 Hebei Changshan Biochemical PharmaceuticalCN„14.3512.4%
+CN„1.5b
134.9%PS7.8x
688091 Shanghai Yizhong PharmaceuticalCN„65.7915.3%
+CN„1.4b
-2.7%PE61.5x
2262 Jiangsu Nhwa PharmaceuticalCN„26.674.8%
+CN„1.2b
28.8%PE25.7x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

688091

CN„65.79

Shanghai Yizhong Pharmaceutical

7D

15.3%

1Y

-2.7%

688578

CN„46.69

Shanghai Allist Pharmaceuticals

7D

21.3%

1Y

129.8%

2821

CN„121.03

Asymchem Laboratories (Tianjin)

7D

-14.2%

1Y

-11.1%

300765

CN„38.04

CSPC Innovation Pharmaceutical

7D

-13.6%

1Y

276.2%

600085

CN„50.96

Beijing Tongrentang

7D

-3.4%

1Y

4.2%

300705

CN„36.96

Hunan Jiudian Pharmaceutical

7D

10.4%

1Y

49.9%

600196

CN„27.20

Shanghai Fosun Pharmaceutical (Group)

7D

-2.8%

1Y

-26.5%

600535

CN„15.74

Tasly Pharmaceutical Group

7D

2.9%

1Y

33.7%

661

CN„151.36

Changchun High-Tech Industries (Group)

7D

-4.7%

1Y

-15.1%

603456

CN„25.40

Zhejiang Jiuzhou Pharmaceutical

7D

-9.7%

1Y

-35.1%

766

CN„23.66

Tonghua Golden-Horse Pharmaceutical Industry CoLtd

7D

35.6%

1Y

293.7%

2262

CN„26.67

Jiangsu Nhwa Pharmaceutical

7D

4.8%

1Y

28.8%

600276

CN„45.59

Jiangsu Hengrui Medicine

7D

-2.1%

1Y

17.4%

300573

CN„172.85

Shenyang Xingqi PharmaceuticalLtd

7D

5.5%

1Y

67.0%

600436

CN„242.20

Zhangzhou Pientzehuang Pharmaceutical

7D

-3.9%

1Y

-11.3%

300255

CN„14.35

Hebei Changshan Biochemical Pharmaceutical

7D

12.4%

1Y

134.9%